239 related articles for article (PubMed ID: 24985952)
1. Tubular calcium reabsorption and other aspects of calcium homeostasis in primary and secondary hyperparathyroidism.
Phelps KR; Stote KS; Mason D
Clin Nephrol; 2014 Aug; 82(2):83-91. PubMed ID: 24985952
[TBL] [Abstract][Full Text] [Related]
2. Reduced parathyroid hormone-stimulated 1,25-dihydroxyvitamin d production in vitamin d sufficient postmenoposual women with low bone mass and idiopathic secondary hyperparathyroidism.
Streeten EA; Rogstad AS; Flammer KM; Zarbalian K; Ryan K; Horwitz M; Holick MF; Shelton J
Endocr Pract; 2013; 19(1):91-9. PubMed ID: 23186957
[TBL] [Abstract][Full Text] [Related]
3. 1,25-dihydroxyvitamin D suppresses circulating levels of parathyroid hormone in a patient with primary hyperparathyroidism and coexistent sarcoidosis.
Kinoshita Y; Taguchi M; Takeshita A; Miura D; Tomikawa S; Takeuchi Y
J Clin Endocrinol Metab; 2005 Dec; 90(12):6727-31. PubMed ID: 16159932
[TBL] [Abstract][Full Text] [Related]
4. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
5. Parathyroid Hormone, Fibroblast Growth Factor 23, and Parameters of Phosphate Reabsorption.
Phelps KR; Mason DL
Am J Nephrol; 2018; 47(5):343-351. PubMed ID: 29779023
[TBL] [Abstract][Full Text] [Related]
6. Tradeoff-in-the-Nephron: A Theory to Explain the Primacy of Phosphate in the Pathogenesis of Secondary Hyperparathyroidism.
Phelps KR
Nutrients; 2017 Apr; 9(5):. PubMed ID: 28445401
[TBL] [Abstract][Full Text] [Related]
7. Use of sevelamer to examine the role of intraluminal phosphate in the pathogenesis of secondary hyperparathyroidism.
Phelps KR; Stote KS; Mason D
Clin Nephrol; 2014 Sep; 82(3):191-201. PubMed ID: 25079864
[TBL] [Abstract][Full Text] [Related]
8. Hyperparathyroidism and 1,25-dihydroxyvitamin D deficiency in mild, moderate, and severe renal failure.
Pitts TO; Piraino BH; Mitro R; Chen TC; Segre GV; Greenberg A; Puschett JB
J Clin Endocrinol Metab; 1988 Nov; 67(5):876-81. PubMed ID: 3182962
[TBL] [Abstract][Full Text] [Related]
9. Phosphate homeostasis, parathyroid hormone, and fibroblast growth factor 23 in stages 3 and 4 chronic kidney disease.
Phelps KR; Mason DL; Stote KS
Clin Nephrol; 2016 May; 85(5):251-61. PubMed ID: 26951967
[TBL] [Abstract][Full Text] [Related]
10. Normocalcemic primary hyperparathyroidism: resistance to PTH effect on tubular reabsorption of calcium.
Gardin JP; Paillard M
Miner Electrolyte Metab; 1984; 10(5):301-8. PubMed ID: 6493158
[TBL] [Abstract][Full Text] [Related]
11. Vitamin D retains an important role in the pathogenesis and management of secondary hyperparathyroidism in chronic renal failure.
Cozzolino M; Gallieni M; Brancaccio D; Arcidiacono T; Bianchi G; Vezzoli G
J Nephrol; 2006; 19(5):566-77. PubMed ID: 17136683
[TBL] [Abstract][Full Text] [Related]
12. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
Lorenzo Sellares V; Torregrosa V
Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
[TBL] [Abstract][Full Text] [Related]
13. Serum calcium (S-Ca), the forgotten test: preliminary results of an appropriateness strategy to detect primary hyperparathyroidism (pHPT).
Salinas M; López-Garrigós M; Pomares F; Lugo J; Asencio A; López-Penabad L; Dominguez JR; Leiva-Salinas C
Bone; 2013 Sep; 56(1):73-6. PubMed ID: 23707628
[TBL] [Abstract][Full Text] [Related]
14. An examination of multiple explanations for secondary hyperparathyroidism
.
Phelps KR; Mason DL
Clin Nephrol; 2020 Aug; 94(2):70-77. PubMed ID: 32567541
[TBL] [Abstract][Full Text] [Related]
15. Chemical evidence for the tradeoff-in-the-nephron hypothesis to explain secondary hyperparathyroidism.
Phelps KR; Gemoets DE; May PM
PLoS One; 2022; 17(8):e0272380. PubMed ID: 35913960
[TBL] [Abstract][Full Text] [Related]
16. Gestational hypercalcemia: Prevalence and biochemical profile.
Schoenmakers I; Piec I; Baban S; Bärebring L; Green D; Washbourne CJ; Tang JCY; Fraser WD; Augustin H
J Steroid Biochem Mol Biol; 2020 May; 199():105611. PubMed ID: 32007562
[TBL] [Abstract][Full Text] [Related]
17. The role of vitamin D in mild to moderate chronic kidney disease.
Friedman TC; Norris KC
Trends Endocrinol Metab; 2002 Jul; 13(5):189-94. PubMed ID: 12185664
[TBL] [Abstract][Full Text] [Related]
18. [Effect of calcium on N-terminal truncation of PTH in human parathyroid cells].
Kawata T; Imanishi Y; Kobayashi K; Tahara H; Ishimura E; Inaba M; Nishizawa Y; Takemoto Y; Onoda N; Okuno S; Ishikawa T
Clin Calcium; 2005 Sep; 15 Suppl 1():98-100; discussion 100-1. PubMed ID: 16279017
[TBL] [Abstract][Full Text] [Related]
19. Survey of attitudes of physicians toward the current evaluation and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD).
Souqiyyeh MZ; Shaheen FA
Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):93-101. PubMed ID: 20061700
[TBL] [Abstract][Full Text] [Related]
20. Predictors of renal function in primary hyperparathyroidism.
Walker MD; Nickolas T; Kepley A; Lee JA; Zhang C; McMahon DJ; Silverberg SJ
J Clin Endocrinol Metab; 2014 May; 99(5):1885-92. PubMed ID: 24527717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
